Mirae Asset Global Investments
KYMR icon

Mirae Asset Global Investments’s Kymera Therapeutics KYMR Stock Holding History

Mirae Asset Global Investments’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Sell
3,679
-579
-14% -$49.7K ﹤0.01% 1010
2026
Q1 		$355K Buy
4,258
+762
+22% +$60.3K ﹤0.01% 996
2025
Q4 		$272K Buy
3,496
+732
+26% +$49.4K ﹤0.01% 1100
2025
Q3 		$156K Buy
2,764
+248
+10% +$11.2K ﹤0.01% 1152
2025
Q2 		$110K Buy
2,516
+343
+16% +$11.8K ﹤0.01% 1123
2025
Q1 		$64.4K Buy
2,173
+15
+0.7% +$547 ﹤0.01% 1192
2024
Q4 		$86.6K Sell
2,158
-178
-8% -$8.04K ﹤0.01% 1173
2024
Q3 		$114K Buy
2,336
+504
+28% +$22.3K ﹤0.01% 1168
2024
Q2 		$55.4K Sell
1,832
-22,639
-93% -$784K ﹤0.01% 1230
2024
Q1 		$787K Buy
24,471
+1,531
+7% +$54.8K ﹤0.01% 1661
2023
Q4 		$584K Buy
22,940
+524
+2% +$9.37K ﹤0.01% 1888
2023
Q3 		$312K Sell
22,416
-2,454
-10% -$49.3K ﹤0.01% 2107
2023
Q2 		$567K Sell
24,870
-698
-3% -$20K ﹤0.01% 1887
2023
Q1 		$758K Buy
25,568
+7,894
+45% +$255K ﹤0.01% 1688
2022
Q4 		$441K Buy
17,674
+621
+4% +$16.6K ﹤0.01% 1960
2022
Q3 		$371K Buy
17,053
+6,036
+55% +$159K ﹤0.01% 2054
2022
Q2 		$217K Buy
+11,017
New +$257K ﹤0.01% 2122

Other funds holding KYMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Mirae Asset Global Investments's KYMR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Kymera Therapeutics (KYMR) stake by 14% in Q2 2026, selling an estimated $49.7K and leaving 3,679 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Mirae Asset Global Investments first reported a position in KYMR in Q2 2022 and has held it in 17 quarters since. The position peaked at $787K in Q1 2024. 99 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Mirae Asset Global Investments held 3,679 shares of Kymera Therapeutics worth $422K as of Q2 2026.
  • Mirae Asset Global Investments sold 579 Kymera Therapeutics shares in Q2 2026, an estimated $49.7K.
  • Kymera Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1010 holding.
  • Mirae Asset Global Investments first reported a position in Kymera Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Kymera Therapeutics position peaked at $787K in Q1 2024.
  • 99 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.